Deng HY, Qiu XM, Zhu DX, Tang XJ, et al. The safety and feasibility of preoperative induction therapy of Savolitinib in non-small cell lung cancer patients with MET exon 14 skipping mutation. J Cancer Res Clin Oncol 2022 Sep 28. pii: 10.1007/s00432-022-04370.
PMID: 36171456